Cargando…
IL-1β Pretreatment Improves the Efficacy of Mesenchymal Stem Cells on Acute Liver Failure by Enhancing CXCR4 Expression
BACKGROUND: Mesenchymal stem cells (MSCs), with the powerful metabolic and functional supporting abilities for inflammatory diseases, may be an effective therapeutic strategy for acute liver failure (ALF). However, the efficacy of MSCs can still be promoted if pretreatment is applied to enhance thei...
Autores principales: | Nie, He, An, Fangmei, Mei, Jie, Yang, Cheng, Zhan, Qiang, Zhang, Qinglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364198/ https://www.ncbi.nlm.nih.gov/pubmed/32724311 http://dx.doi.org/10.1155/2020/1498315 |
Ejemplares similares
-
Decreased SLC39A1 (Solute carrier family 39 member 1) expression predicts unfavorable prognosis in patients with early-stage hepatocellular carcinoma
por: Zhang, Qinglin, et al.
Publicado: (2021) -
Dishevelled-Associated Activator of Morphogenesis 2 (DAAM2) Predicts the Immuno-Hot Phenotype in Pancreatic Adenocarcinoma
por: Zhang, Qinglin, et al.
Publicado: (2022) -
Mesenchymal Stem Cell Therapy in Acute Liver Failure
por: Wang, Yong-Hong, et al.
Publicado: (2023) -
Formin protein FMNL1 is a biomarker for tumor-infiltrating immune cells and associated with well immunotherapeutic response
por: Lu, Guomin, et al.
Publicado: (2023) -
TGFβ(1)
priming enhances CXCR3‐mediated mesenchymal stromal cell engraftment to the liver and enhances anti‐inflammatory efficacy
por: Garg, Abhilok, et al.
Publicado: (2023)